Weill Cornell Medicine - New York Presbyterian is a clinical research site located in New York, New York, United States.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Weill Cornell Medicine - New York Presbyterian has participated in 2 clinical trials.
Therapeutic areas: Metastatic Castration-Resistant Prostate Cancer, Multiple Myeloma in Relapse.
Sponsors: Zenith Epigenetics, Travera Inc.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Weill Cornell Medicine - New York Presbyterian has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Weill Cornell Medicine - New York Presbyterian has 2 clinical trials on record. Their work covers Metastatic Castration-Resistant Prostate Cancer, Multiple Myeloma in Relapse.
Weill Cornell Medicine - New York Presbyterian has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.